Intercept Pharmaceuticals, Inc. et al v. Apotex Inc. et al
| Intercept Pharmaceuticals, Inc. and Intercept Pharma Europe LTD. |
| Apotex Inc. and Apotex Corp. |
| 1:2020cv01105 |
| August 21, 2020 |
| US District Court for the District of Delaware |
| Maryellen Noreika |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. ยง 271 |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on September 1, 2022. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Pro Hac Vice Attorney Mary Swears for Intercept Pharma Europe LTD., for Intercept Pharmaceuticals, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (myr) |
| Filing 9 WAIVER OF SERVICE returned executed by Intercept Pharmaceuticals, Inc., Intercept Pharma Europe LTD.: For Apotex Inc. waiver sent on 8/28/2020, answer due 10/27/2020. (Blumenfeld, Jack) |
| Filing 8 WAIVER OF SERVICE returned executed by Intercept Pharmaceuticals, Inc., Intercept Pharma Europe LTD.: For Apotex Corp. waiver sent on 8/28/2020, answer due 10/27/2020. (Blumenfeld, Jack) |
SO ORDERED re #7 MOTION for Pro Hac Vice Appearance of Attorney Christopher Sipes, Jeffrey B. Elikan, Megan Keane, Jeremy Cobb, Laura Dolbow, and Mary Swears filed by Intercept Pharmaceuticals, Inc., Intercept Pharma Europe LTD. ORDERED by Judge Maryellen Noreika on 8/27/2020. (dlw)
|
| Pro Hac Vice Attorney Jeffrey B. Elikan for Intercept Pharma Europe LTD., for Intercept Pharmaceuticals, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (myr) |
| Case Assigned to Judge Maryellen Noreika. Please include the initials of the Judge (MN) after the case number on all documents filed. (rjb) |
| Filing 7 MOTION for Pro Hac Vice Appearance of Attorney Christopher Sipes, Jeffrey B. Elikan, Megan Keane, Jeremy Cobb, Laura Dolbow, and Mary Swears - filed by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc.. (Blumenfeld, Jack) |
| Filing 6 Summonses Issued as to Apotex Corp. and Apotex Inc. (please complete the top portion of the form and print out for use/service). (Attachments: #1 Summons- Apotex Corp)(sam) |
| CORRECTING ENTRY: D.I. 7 deleted. Document was intended for a different case. (sam) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc.. (sam) |
| Filing 4 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: not earlier than 07/13/2020. Date of Expiration of Patent: See Attached.Thirty Month Stay Deadline: 11/27/2023. (sam) |
| Filing 3 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,238,673 B2 ;10,047,117 B2 ;10,052,337 B2 ;10,174,073 B2. (sam) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (sam) |
| Filing 1 COMPLAINT for Patent Infringement filed against Apotex Corp., Apotex Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number ADEDC-3146824.) - filed by Intercept Pharmaceuticals, Inc., Intercept Pharma Europe LTD.. (Attachments: #1 Exhibit A-E, #2 Civil Cover Sheet)(sam) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
